SEC Form 4Coverage since Aug 6, 2026
$AMGN insider trading
Over the last 12 months, Amgen insiders reported no purchases and 2 sales totaling $2.8M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $2.8M 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $AMGN · 12Mvia TradingView
Top insiders · 12m
Grygiel Nancy A.SVP & CCO1× · $1.2M
Miller DerekSVP, Human Resources1× · $1.6M
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Miller DerekSVP, Human Resources · O | ▼ Sale | 3,890 | $402.54 | $1.6M | -23.8% | 2 tranches |
| Aug 6, 2026 | Grygiel Nancy A.SVP & CCO · O | ▼ Sale | 2,970 | $402.16 | $1.2M | -28.8% | 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AMGN feed.